Novartis wins Gilenya reprieve as judge blocks generics, for now

Novartis has won a U.S. federal court order preventing rival generic makers from selling versions of the Swiss drugmaker's top-selling multiple sclerosis medicine Gilenya in the United States, at least until a patent dispute is resolved.

from Reuters: Health News https://reut.rs/2X67sQp